Systemic scleroderma (progressive systemic sclerosis) is a connective tissue disorder of
unknown etiology. According to Talbott, 1 the disease is ultimately fatal, although duration of life …

THE occurrence of ocular lesions of variable severity in patients with rheumatoid arthritis,
discoid and systemic lupus erythematosus and other diseases who have received long-term …

The highly favourable benefit-to-risk ratio when using antimalarial drugs in arthritis therapy
has been reconfirmed in every clinical study of the last decade. The efficacy closely …

The cardinal symptom of intervertebral disk infection in 10 patients was sudden excruciating
back pain that frequently radiated down one leg or both legs and usually was not relieved …

DMSO exerts a palliative, therapeutic effect on healing of cutaneous ulcers in systemic
sclerosis. The therapeutic response was variable and, therefore, the concentration of DMSO, as …

Discussion Osteolysis of the tufts of the terminal phalanges of the fingers is the most
common

RESULTS Response to serotonin.’1’wenty patients from the group of 23 patients with
rheumatoid arthritis and 8 of the 9 patients with systemic lupus erythematosus demonstrated …

New antirheumatic drugs which are moderately effective clinically and less toxic than similarly
acting, previously available drugs are believed to act by blocking certain mediators of …

A NEW antirheumatic agent, oxyphenbutazone (p-hydroxyphenylbutazone) synthesized by
pfister and Häfliger, 1 has been found to be identical with Metabolite I, discovered by Burns …

Monoamine oxidase is a complex enzyme system widely distributed in the body and is believed
to be of primary importance in health and disease. Since the early work with iproniazid, …